Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.70 +0.32 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Shares Outstanding (Entity) (2013 - 2026)

Atara Biotherapeutics (ATRA) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 Atara Biotherapeutics 141.08 Mn 124.53 Mn 439,000.00 15.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 15.03 Mn
Mar 31, 2026 14.08 Mn
Dec 31, 2025 12.54 Mn
Sep 30, 2025 13.56 Mn
Jun 30, 2025 12.20 Mn
Mar 31, 2025 10.76 Mn
Dec 31, 2024 7.49 Mn
Sep 30, 2024 7.47 Mn
Jun 30, 2024 6.14 Mn
Mar 31, 2024 4.81 Mn
Dec 31, 2023 4.26 Mn
Sep 30, 2023 4.26 Mn
Jun 30, 2023 4.04 Mn
Mar 31, 2023 3.86 Mn
Dec 31, 2022 3.84 Mn
Sep 30, 2022 3.80 Mn
Jun 30, 2022 3.77 Mn
Mar 31, 2022 3.74 Mn
Dec 31, 2021 3.67 Mn
Sep 30, 2021 3.54 Mn